Drug Channels Institute (DCI) is a leading source of industry research about pharmaceutical economics and the drug distribution system. >

E-LEARNING MODULES

DCI delivers educational solutions for clients that enhance the business acumen of employees, from senior executives to field reps to internal operations. State-of-the-art instructional design, coupled with extensive industry knowledge, allows DCI to build rigorous programs with accurate, fact-based content reflecting the latest developments. Even better, we deliver the material in an engaging, accessible manner using turn-key technology solutions. View a sample of our modules

View Sample

Industry Reports

The 2026 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers

The ultimate guide to the complex web of interactions within the U.S. prescription distribution and reimbursement system more >

The 2025-26 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors

The most comprehensive tool for analyzing the economic and business realities of the U.S. pharmaceutical distribution industry. more >

From The Drug Channels Blog

When Access Tightens, Prior Authorization Execution Becomes the Differentiator

Today's guest post comes from Megan Wetzel, Vice President of Product, Access and Affordability at CoverMyMeds. Megan examines how prior authorization execution has become a strategic differentiator for biopharma more >

The Hidden Cost of 340B for Employers and Health Plans

By Adam J. Fein, Ph.D.For years, the controversy surrounding the 340B Drug Pricing Program has centered on hospitals, manufacturers, and contract pharmacies. But employers and health plans more >